CONFIDENTIALITY & NON-DISCLOSURE AGREEMENTNon-Disclosure Agreement • January 11th, 2021 • Washington
Contract Type FiledJanuary 11th, 2021 JurisdictionACT Capital Advisors, LLC. ("ACT') is acting as an advisor to the company identified as ACT Client Number #20601 (the "Company"). In connection with your interest in a potential transaction by you or one of your affiliates or assigns involving the Company (a "Transaction") you have requested non-public information from ACT with respect to the Company (hereafter collectively referred to as the "Confidential Material"). For purposes of this Agreement, the term Confidential Material shall include all information, regardless of the form in which it is communicated (whether prepared by the ACT or the Company or otherwise) that contains or otherwise reflects information concerning the Company that you or your directors, officers, employees, partners, affiliates, agents, advisors, attorneys or representatives (the "Representatives") may be provided by or on behalf of the Company in the course of your evaluation of a potential Transaction . The term Confidential Material shall also include all
CONFIDENTIALITY & NON-DISCLOSURE AGREEMENTNon-Disclosure Agreement • December 30th, 2020 • Washington
Contract Type FiledDecember 30th, 2020 JurisdictionACT Capital Advisors, LLC. ("ACT') is acting as an advisor to the company identified as ACT Client Number #20303 (the "Company"). In connection with your interest in a potential transaction by you or one of your affiliates or assigns involving the Company (a "Transaction") you have requested non-public information from ACT with respect to the Company (hereafter collectively referred to as the "Confidential Material"). For purposes of this Agreement, the term Confidential Material shall include all information, regardless of the form in which it is communicated (whether prepared by the ACT or the Company or otherwise) that contains or otherwise reflects information concerning the Company that you or your directors, officers, employees, partners, affiliates, agents, advisors, attorneys or representatives (the "Representatives") may be provided by or on behalf of the Company in the course of your evaluation of a potential Transaction . The term Confidential Material shall also include all
CONFIDENTIALITY & NON-DISCLOSURE AGREEMENTNon-Disclosure Agreement • April 16th, 2019 • Washington
Contract Type FiledApril 16th, 2019 JurisdictionACT Capital Advisors, LLC. (“ACT”) is acting as an advisor to the company identified as Project Antilles (the “Company”). In connection with your interest in a potential transaction by you or one of your affiliates or assigns involving the Company (a “Transaction”) you have requested non-public information from ACT with respect to the Company (hereafter collectively referred to as the “Confidential Material”). For purposes of this Agreement, the term Confidential Material shall include all information, regardless of the form in which it is communicated (whether prepared by the ACT or the Company or otherwise) that contains or otherwise reflects information concerning the Company that you or your directors, officers, employees, partners, affiliates, agents, advisors, attorneys or representatives (the “Representatives”) may be provided by or on behalf of the Company in the course of your evaluation of a potential Transaction. The term Confidential Material shall also include all analyses
CONFIDENTIALITY & NON-DISCLOSURE AGREEMENTNon-Disclosure Agreement • November 2nd, 2018 • Washington
Contract Type FiledNovember 2nd, 2018 JurisdictionACT Capital Advisors, LLC. (“ACT”) is acting as an advisor to the company identified as ACT Client Number 18402 (the “Company”). In connection with your interest in a potential transaction by you or one of your affiliates or assigns involving the Company (a “Transaction”) you have requested non-public information from ACT with respect to the Company (hereafter collectively referred to as the “Confidential Material”). For purposes of this Agreement, the term Confidential Material shall include all information, regardless of the form in which it is communicated (whether prepared by the ACT or the Company or otherwise) that contains or otherwise reflects information concerning the Company that you or your directors, officers, employees, partners, affiliates, agents, advisors, attorneys or representatives (the “Representatives”) may be provided by or on behalf of the Company in the course of your evaluation of a potential Transaction. The term Confidential Material shall also include all a